1. Home
  2. DAN vs HRMY Comparison

DAN vs HRMY Comparison

Compare DAN & HRMY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Dana Incorporated

DAN

Dana Incorporated

HOLD

Current Price

$22.74

Market Cap

2.4B

ML Signal

HOLD

Logo Harmony Biosciences Holdings Inc.

HRMY

Harmony Biosciences Holdings Inc.

HOLD

Current Price

$40.40

Market Cap

2.0B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
DAN
HRMY
Founded
1904
2017
Country
United States
United States
Employees
N/A
N/A
Industry
Auto Parts:O.E.M.
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.4B
2.0B
IPO Year
N/A
2020

Fundamental Metrics

Financial Performance
Metric
DAN
HRMY
Price
$22.74
$40.40
Analyst Decision
Buy
Strong Buy
Analyst Count
5
9
Target Price
$26.40
$51.33
AVG Volume (30 Days)
1.8M
765.2K
Earning Date
10-29-2025
11-04-2025
Dividend Yield
1.76%
N/A
EPS Growth
N/A
50.44
EPS
0.39
3.17
Revenue
$9,957,000,000.00
$825,944,000.00
Revenue This Year
N/A
$23.11
Revenue Next Year
$2.05
$16.15
P/E Ratio
$58.34
$12.79
Revenue Growth
17.78
21.13
52 Week Low
$10.11
$25.52
52 Week High
$23.24
$40.93

Technical Indicators

Market Signals
Indicator
DAN
HRMY
Relative Strength Index (RSI) 59.87 80.09
Support Level $22.05 $38.12
Resistance Level $22.88 $40.00
Average True Range (ATR) 0.78 1.20
MACD 0.06 0.25
Stochastic Oscillator 78.91 100.00

Price Performance

Historical Comparison
DAN
HRMY

About DAN Dana Incorporated

Dana Inc is engaged in the designing and manufacturing of efficient propulsion and energy-management solutions that power vehicles and machines in all mobility markets across the globe. The company has four operating segments: Light Vehicles, Power Technologies, Commercial Vehicle, and Off-Highway. The Light Vehicles segment generates the majority portion of revenue by providing products to support light vehicle OEMs. Its products are designed for light trucks, SUVs, CUVs, vans, and passenger cars.

About HRMY Harmony Biosciences Holdings Inc.

Harmony Biosciences Holdings Inc is a commercial-stage pharmaceutical company focused on developing and commercializing therapies for patients living with rare neurological diseases who have unmet medical needs. The company's product WAKIX (pitolisant) is a molecule with a novel mechanism of action specifically designed to increase histamine signaling in the brain by binding to H3 receptors and is used for the treatment of cataplexy in adult patients with narcolepsy. The other drug candidates in its pipeline are Pitolisant, HBS-102 (MCHR1 antagonist), BP1.15205 (orexin-2 receptor agonist), ZYN002 (cannabidiol gel), EPX-100 (clemizole hydrochloride), and EPX-200 (lorcaserin), among others.

Share on Social Networks: